Company Overview of Novo Nordisk, Inc.
Novo Nordisk, Inc. operates as a healthcare company that focuses on diabetes care. The company provides diabetes pharmaceuticals and insulin delivery systems. It also specializes in hemophilia care, growth hormone therapy, and hormone replacement therapy. The company was incorporated in 1982 and is headquartered in Princeton, New Jersey. It has a manufacturing facility in Clayton, North Carolina; and a research and development center in Seattle, Washington. Novo Nordisk, Inc. operates as a subsidiary of Novo Nordisk A/S.
100 College Road West
Princeton, NJ 08540
Founded in 1982
Key Executives for Novo Nordisk, Inc.
Novo Nordisk, Inc. Key Developments
Similar Private Companies By Industry
|Palingen, Inc.||United States|
|Auricx Pharmaceuticals, Inc.||United States|
|CIBA Vision Puerto Rico, Inc.||United States|
|Bayer Pharmaceuticals Corporation||United States|
|Theranutrients, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Novo Nordisk, Inc., please visit www.novonordisk-us.com. Company data is provided by Capital IQ. Please use this form to report any data issues.